Skip Navigation

Cardiovascular Research 2004 61(2):339-351; doi:10.1016/j.cardiores.2003.09.027
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hayashi, T.
Right arrow Articles by Ignarro, L. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayashi, T.
Right arrow Articles by Ignarro, L. J
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Gene transfer of endothelial NO synthase, but not eNOS, plus inducible NOS regressed atherosclerosis in rabbits

Toshio Hayashia,*, Daigo Sumib, Packiasamy A.R Julieta, Hisako Matsui-Hiraia, Yukako Asai-Tanakaa, Hatsuyo Kanoa, Akiko Fukatsua, Taku Tsunekawaa, Asaka Miyazakia, Akihisa Iguchia and Louis J Ignarrob

aDepartment of Geriatrics, Nagoya University Graduate School of Medicine, 65 Tsuruma-cho, Showa, Nagoya 466-8550, Japan
bDepartment of Molecular and Medical Pharmacology, University of California at Los Angeles, School of Medicine, California, USA

* Corresponding author. Tel.: +81-52-744-2364; fax: +81-52-744-2371. hayashi{at}med.nagoya-u.ac.jp

The effects of in vivo gene transfer of endothelial nitric oxide synthase (eNOS) and inducible NOS (iNOS) genes on severe atherosclerosis were investigated in rabbits. The recombinant adenoviruses, Ad.eNOS and Ad.iNOS, which respectively express eNOS and iNOS, were constructed. Atherosclerosis was induced by a balloon injury followed by a high cholesterol diet for 12 weeks. The rabbits were divided into six groups: Gp cont (no treatment); Gp null (adenovirus sham-infected); Gp eNOS (Ad.eNOS); Gp iNOS (Ad.iNOS); Gp e+i (Ad.eNOS plus Ad.iNOS); and Gp heNOS (a high dose of Ad.eNOS). Examinations were carried out 7 days after gene transfer. Plasma lipid levels were not significantly changed, but transfection with Ad.eNOS (Gp eNOS and Gp heNOS) decreased the tissue cholesterol concentration and regressed atherosclerotic lesions. Vessels treated with Ad.iNOS (Gp iNOS and Gp e+i) showed iNOS staining in the atheroma, and slight staining at other parts of the vessels; those treated with Ad.eNOS showed eNOS staining in the endothelium and subintima, and slight staining at other parts. Ad.eNOS transfection, but not Ad.iNOS or Ad.eNOS+Ad.iNOS transfection, improved the impaired aortic endothelium-dependent relaxation (EDR) and basal NO-dependent response, increased tissue cyclic GMP (cGMP), and decreased the release of O2 from vessels. eNOS treatment showed a decreasing tendency in regions with peroxynitrite staining, MMP1 staining, and suspected apoptosis. In conclusion, in vivo gene transfer of eNOS, but not iNOS or eNOS plus iNOS, regressed atherosclerosis. The relations among NO, O2, and peroxynitrite may be critical, and lipid resorption from the lesions may be responsible for the regression.

KEYWORDS Atherosclerosis; Nitric oxide; Gene theraphy

Abbreviations: NO, Nitric oxide • NOS, Nitric oxide synthase • eNOS, endothelial nitric oxide synthase • iNOS, inducible nitric oxide synthase • NTG, nitroglycerin • EDR, endothelium-dependent relaxation • L-NMA, NG-monomethyl-L-arginine acetate, inhibitor of NO synthase • ACh, acetylcholine chloride • SOD, superoxide dismutase • PGF2{alpha}, prostaglandin F2{alpha}


Time for primary review 44 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
B. Ramkhelawon, J. Vilar, D. Rivas, B. Mees, R. de Crom, A. Tedgui, and S. Lehoux
Shear Stress Regulates Angiotensin Type 1 Receptor Expression in Endothelial Cells
Circ. Res., October 23, 2009; 105(9): 869 - 875.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Daum, A. Grabski, and M.A. Reidy
Sphingosine 1-Phosphate: A Regulator of Arterial Lesions
Arterioscler Thromb Vasc Biol, October 1, 2009; 29(10): 1439 - 1443.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Zhang, S. Zhuang, D. E. Casteel, D. J. Looney, G. R. Boss, and R. B. Pilz
A Cysteine-rich LIM-only Protein Mediates Regulation of Smooth Muscle-specific Gene Expression by cGMP-dependent Protein Kinase
J. Biol. Chem., November 16, 2007; 282(46): 33367 - 33380.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
C. Napoli and L. J Ignarro
Polymorphisms in endothelial nitric oxide synthase and carotid artery atherosclerosis
J. Clin. Pathol., April 1, 2007; 60(4): 341 - 344.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
P. Pacher, J. S. Beckman, and L. Liaudet
Nitric Oxide and Peroxynitrite in Health and Disease
Physiol Rev, January 1, 2007; 87(1): 315 - 424.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi, H. Matsui-Hirai, A. Miyazaki-Akita, A. Fukatsu, J. Funami, Q.-F. Ding, S. Kamalanathan, Y. Hattori, L. J. Ignarro, and A. Iguchi
Endothelial cellular senescence is inhibited by nitric oxide: Implications in atherosclerosis associated with menopause and diabetes
PNAS, November 7, 2006; 103(45): 17018 - 17023.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Theilmeier, C. Schmidt, J. Herrmann, P. Keul, M. Schafers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, et al.
High-Density Lipoproteins and Their Constituent, Sphingosine-1-Phosphate, Directly Protect the Heart Against Ischemia/Reperfusion Injury In Vivo via the S1P3 Lysophospholipid Receptor
Circulation, September 26, 2006; 114(13): 1403 - 1409.
[Abstract] [Full Text] [PDF]


Home page
Clin Med ResHome page
Z. Yang and X.-F. Ming
Recent advances in understanding endothelial dysfunction in atherosclerosis.
Clin. Med. Res., March 1, 2006; 4(1): 53 - 65.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Hayashi, P. A. R. Juliet, H. Matsui-Hirai, A. Miyazaki, A. Fukatsu, J. Funami, A. Iguchi, and L. J. Ignarro
L-citrulline and L-arginine supplementation retards the progression of high-cholesterol-diet-induced atherosclerosis in rabbits
PNAS, September 20, 2005; 102(38): 13681 - 13686.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. T. Bolick, S. Srinivasan, K. W. Kim, M. E. Hatley, J. J. Clemens, A. Whetzel, N. Ferger, T. L. Macdonald, M. D. Davis, P. S. Tsao, et al.
Sphingosine-1-Phosphate Prevents Tumor Necrosis Factor-{alpha}-Mediated Monocyte Adhesion to Aortic Endothelium in Mice
Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 976 - 981.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.